Početna › Insulinska rezistencija › Kalifornija
Kliničke studije za Insulinska rezistencija u državi Kalifornija
11 studija za Insulinska rezistencija traži sudionike na lokacijama u državi Kalifornija.
Gradovi u državi Kalifornija
Službeni tekst studije (engleski)
Gauging Outcomes of Total Milk Ingestion on Lipid and gControl
- UCSF Medical Center at Parnassus, San Francisco
U tijeku regrutacijaZdravi dobrovoljci dobrodošli
Od 18 godina i više · Oba spola · Ažurirano 2. lis 2026. · NCT07087184Type 1 Diabetes Extension Study
- UCSF School of Medicine, San Francisco
- Stanford University, Stanford
U tijeku regrutacijaOpažajna studija
Od 8 do 35 godina · Oba spola · Ažurirano 18. ruj 2026. · NCT02734277INHALE-1st: Afrezza® For Youth With Newly-Diagnosed Type 1 Diabetes
- Children's Hospital Los Angeles, Los Angeles
- University of California San Francisco, San Francisco
U tijeku regrutacijaFaza 2
Od 6 do 17 godina · Oba spola · Ažurirano 13. kol 2026. · NCT07224321DECIDE: A Comparative Effectiveness Trial of Metformin Versus Insulin for the Treatment of Gestational Diabetes
- Cedars Sinai Medical Center, Los Angeles
- University of California San Francisco, San Francisco
U tijeku regrutacijaFaza 4
Od 18 godina i više · Žene · Ažurirano 25. lip 2026. · NCT06445946Sodium Bicarbonate and Mitochondrial Energetics in Persons With CKD
- University of California Davis Health, Sacramento
U tijeku regrutacijaFaza 2
Od 21 do 85 godina · Oba spola · Ažurirano 6. svi 2026. · NCT04984226A Single Bolus, 12-hour Euglycemic Clamp Study of the Safety, Pharmacokinetics (PK) and Glucodynamics (GD) of Intraperitoneal (IP) Portal Insulin U-500
- ProSciento, Inc., Chula Vista
U tijeku regrutacijaFaza 1
Od 18 do 60 godina · Oba spola · Ažurirano 28. tra 2026. · NCT07341373Evexomostat Plus PI3K or AKT Inhibitor and Fulvestrant in Patients With a PI3K Alteration and HR+/Her2- Breast Cancer
- Loma Linda University Cancer Center, Loma Linda
- Hoag Memorial Hospital Presbyterian, Newport
- SHARP Healthcare, San Diego
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 22. tra 2026. · NCT05455619Normal-weight Diabetes: Adipocyte-directed Therapy With Pioglitazone or Tirzepatide
- Stanford University, Palo Alto
- Stanford University, Clinical and Translational Research Unit (CTRU), Stanford
U tijeku regrutacijaFaza 4Zdravi dobrovoljci dobrodošli
Od 30 do 70 godina · Oba spola · Ažurirano 20. tra 2026. · NCT06657209Effects of Sabroxy® Supplementation on Insulin Resistance and Cognitive Function in Adults With Mild Cognitive Impairment and Insulin Resistance
- San Francisco Research Institute, San Francisco
U tijeku regrutacijaZdravi dobrovoljci dobrodošli
Od 40 do 80 godina · Oba spola · Ažurirano 28. sij 2026. · NCT07220694Obesity, Insulin Resistance, and PASC: Persistent SARS-CoV-2
- Stanford Health, Palo Alto
U tijeku regrutacijaZdravi dobrovoljci dobrodošli
Od 18 do 80 godina · Oba spola · Ažurirano 4. pro 2024. · NCT05833217Longitudinal Multi-Omic Profiles to Reveal Mechanisms of Obesity-Mediated Insulin Resistance
- Stanford University, Stanford
U tijeku regrutacijaZdravi dobrovoljci dobrodošli
Od 35 do 65 godina · Oba spola · Ažurirano 4. pro 2024. · NCT05165706Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.